Evidence map›Paper›PMID 31416966›Full record

ArticleGenes & development2019

MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer.

Niranjan Venkateswaran, M Carmen Lafita-Navarro, Yi-Heng Hao, Jessica A Kilgore, Lizbeth Perez-Castro, Jonathan Braverman, Nofit Borenstein-Auerbach, Min Kim, Nicholas P Lesner, Prashant Mishra and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 1 synthesis or guideline pooled it, 277 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Niranjan VenkateswaranDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
M Carmen Lafita-NavarroDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Yi-Heng HaoDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Jessica A KilgoreDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Lizbeth Perez-CastroDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Jonathan BravermanKoch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Nofit Borenstein-AuerbachDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Min KimLydia Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Nicholas P LesnerChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Prashant MishraChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Thomas BrabletzNikolaus-Fiebiger-Center for Molecular Medicine, University Erlangen-Nurnberg, Erlangen 91054, Germany.
Jerry W ShayDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Ralph J DeBerardinisChildren's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Noelle S WilliamsDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Omer H YilmazKoch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Maralice Conacci-SorrellDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
The University of Texas Southwestern Medical Center · USMassachusetts Institute of Technology · USChildren's Medical Center · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
Understanding and Improving Platinum Anticancer DrugsR01CA034992 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YILMAZ, OMER · 1985 to 2018
$6.8M
Project 2U54CA224068 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CORCORAN, RYAN BRUCE, FLAHERTY, KEITH T · 2017 to 2021
$6.3M
The kynurenine-AHR pathway in biomass production - Revision - 2R01CA245548 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CONACCI-SORRELL, MARALICE · 2020 to 2024
$2.2M
Dietary control of stem cells in physiology and cancerR01CA211184 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YILMAZ, OMER · 2017 to 2021
$2.0M
NCI NIH HHS P30 CA014051NCI NIH HHS R01 CA034992NCI NIH HHS R01 CA211184NCI NIH HHS R01 CA245548NCI NIH HHS U54 CA224068
6 · The paper itself

Abstract

Tumors display increased uptake and processing of nutrients to fulfill the demands of rapidly proliferating cancer cells. Seminal studies have shown that the proto-oncogene MYC promotes metabolic reprogramming by altering glutamine uptake and metabolism in cancer cells. How MYC regulates the metabolism of other amino acids in cancer is not fully understood. Using high-performance liquid chromatography (HPLC)-tandem mass spectrometry (LC-MS/MS), we found that MYC increased intracellular levels of tryptophan and tryptophan metabolites in the kynurenine pathway. MYC induced the expression of the tryptophan transporters SLC7A5 and SLC1A5 and the enzyme arylformamidase (AFMID), involved in the conversion of tryptophan into kynurenine. SLC7A5, SLC1A5, and AFMID were elevated in colon cancer cells and tissues, and kynurenine was significantly greater in tumor samples than in the respective adjacent normal tissue from patients with colon cancer. Compared with normal human colonic epithelial cells, colon cancer cells were more sensitive to the depletion of tryptophan. Blocking enzymes in the kynurenine pathway caused preferential death of established colon cancer cells and transformed colonic organoids. We found that only kynurenine and no other tryptophan metabolite promotes the nuclear translocation of the transcription factor aryl hydrocarbon receptor (AHR). Blocking the interaction between AHR and kynurenine with CH223191 reduced the proliferation of colon cancer cells. Therefore, we propose that limiting cellular kynurenine or its downstream targets could present a new strategy to reduce the proliferation of MYC-dependent cancer cells.

Indexed as

Amino Acid Transport System ASCAntineoplastic AgentsArylformamidaseCell LineCell Line, TumorCell ProliferationColonic NeoplasmsGene Expression Regulation, NeoplasticHumansIndolesKynurenineLarge Neutral Amino Acid-Transporter 1Minor Histocompatibility AntigensOximesProto-Oncogene MasProto-Oncogene Proteins c-mycAmino Acid Transport System ASCAntineoplastic AgentsArylformamidaseepacadostatIndolesKynurenineLarge Neutral Amino Acid-Transporter 1MAS1 protein, humanMinor Histocompatibility AntigensMYC protein, humanOximesProto-Oncogene MasProto-Oncogene Proteins c-mycSLC1A5 protein, humanSulfonamidesTDO inhibitor LM10TryptophanAFMIDAHRcancerkynurenineMYCorganoidSLC1A5SLC7A5tryptophan metabolism

Identifiers

PMID31416966
PMCPMC6719621
OpenAlexW2967936362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.